Please login to the form below

restless legs syndrome

This page shows the latest restless legs syndrome news and features for those working in and with pharma, biotech and healthcare.

EC gives nod to restless leg syndrome drug Targin

Mundipharma's Targin has been granted a licence in the EU for the treatment of restless leg syndrome (RLS). ... It is the first opioid to be granted a licence in the EU for RLS, a neurological disorder characterised by an overwhelming urge to move,

Latest news

UCB names Jean-Christophe Tellier as Doliveux's successor

These include already-marketed drugs such as epilepsy therapy Vimpat (lacosamide) and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome (RLS), which are both growing quickly, as well as
Saatchi & Saatchi create Spanish restless legs syndrome campaign

Uncovering Restless Legs Syndrome (Destapando el Síndrome de Piernas Inquietas) has been developed in partnership with Belgium-headquartered pharma company UCB and includes a website with associated blogs, forums and social ... of Restless Legs Syndrome,
US shortage of GSK’s restless legs syndrome treatment Horizant

FDA blames contract manufacturer delays. Delays at GlaxoSmithKline's (GSK) contract manufacturer have caused a shortage in the US of restless legs syndrome treatment Horizant, according to the FDA. ... It is the latest in a long line of problems for
Product updates from Japan

A flurry of new product approvals and filings in Japan includes drugs for pulmonary arterial hypertension, H pylori gastritis, Parkinson's/restless legs syndrome, breast cancer, carnitine deficiency and sedation during ... dentistry. Otsuka
Eliquis and Ryzodeg feature among Japan's year-end approvals

moderate-to-severe idiopathic restless legs syndrome in adults.

More from news
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest Intelligence

Interview: Georg Toufar, Mundipharma

Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.
VIDEO interview: Neil Weir, UCB

epilepsy; and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

XenoPort appoints chief medical officer

Dr Kim has been with the US biopharma company since July 2013, when he joined as VP of medical affair, supporting the marketing of Horizant (gabapentin enacarbil) in restless legs syndrome

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...